Literature DB >> 2185939

Radioiodination of peptide hormones and immunoglobulin preparations: comparison of the chloramine T and iodogen method.

K P Woltanski1, W Besch, H Keilacker, M Ziegler, K D Kohnert.   

Abstract

Following optimization of the reaction conditions, e.g. concentration of oxidizing agents, reaction time, volume of reaction mixture, and pH, chloramine T and the new iodination reagent, Iodogen, were compared for their effectiveness in radioiodination of insulin, glucagon, human growth hormone (hGH), and rabbit anti-mouse IgG. The radioactive peptide hormones prepared were analyzed for the presence of aggregate and breakdown products by polyacrylamide gel electrophoresis (PAGE) at pH 8.9, the rabbit anti-mouse IgG was tested for the presence of low molecular weight damage products by gel filtration on Sephadex G-50. The results demonstrate that with respect to iodine incorporation, specific activity, and immunological reactivity either method can be used to prepare under carefully controlled conditions a wide range of tracers with high specific activity at minimal oxidation damage. These tracers are shown to be highly suitable in radioimmunoassays after previous purification by PAGE and gel filtration, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185939     DOI: 10.1055/s-0029-1210932

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  3 in total

Review 1.  The relevance of pharmacokinetics in the development of biotechnology products.

Authors:  S Toon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

2.  Evaluation of the therapeutic efficacy of sequential therapy involving percutaneous microwave ablation in combination with 131I-hypericin using the VX2 rabbit breast solid tumor model.

Authors:  Miao Zhu; Xiao-An Lin; Xiao-Ming Zha; Wen-Bin Zhou; Tian-Song Xia; Shui Wang
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

3.  A human monoclonal autoantibody to breast cancer identifies the PDZ domain containing protein GIPC1 as a novel breast cancer-associated antigen.

Authors:  Sergei Rudchenko; Matthew Scanlan; Gavreel Kalantarov; Victoria Yavelsky; Chen Levy; Alison Estabrook; Lloyd Old; Gerald L Chan; Leslie Lobel; Ilya Trakht
Journal:  BMC Cancer       Date:  2008-08-24       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.